{"id":"https://openalex.org/W4310108131","doi":"https://doi.org/10.1182/blood-2022-162657","title":"The Burden of Illness and the Incremental Burden of Transfusion Dependence in Myelofibrosis in the United States","display_name":"The Burden of Illness and the Incremental Burden of Transfusion Dependence in Myelofibrosis in the United States","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310108131","doi":"https://doi.org/10.1182/blood-2022-162657"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-162657","doi":"https://doi.org/10.1182/blood-2022-162657","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-162657","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023728016","display_name":"Aaron Thomas Gerds","orcid":"https://orcid.org/0000-0002-3422-1309","observed_orcids":["https://orcid.org/0000-0002-3422-1309"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron T. Gerds","raw_affiliation_strings":["1Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046827092","display_name":"Claire N. Harrison","orcid":"https://orcid.org/0000-0002-3212-920X","observed_orcids":["https://orcid.org/0000-0002-3212-920X"]},"institutions":[{"id":"https://openalex.org/I1324925910","display_name":"St Thomas' Hospital","ror":"https://ror.org/054gk2851","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324925910","https://openalex.org/I200166805","https://openalex.org/I4210111135"]},{"id":"https://openalex.org/I200166805","display_name":"Guy's and St Thomas' NHS Foundation Trust","ror":"https://ror.org/00j161312","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I200166805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Claire Harrison","raw_affiliation_strings":["2Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1324925910","https://openalex.org/I200166805"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stephen Thompson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Thompson","raw_affiliation_strings":["3Sierra Oncology, Inc., San Mateo, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Sierra Oncology, Inc., San Mateo, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075414575","display_name":"Frank Snopek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank Snopek","raw_affiliation_strings":["3Sierra Oncology, Inc., San Mateo, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Sierra Oncology, Inc., San Mateo, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088307376","display_name":"Naveen Pemmaraju","orcid":"https://orcid.org/0000-0002-1670-6513","observed_orcids":["https://orcid.org/0000-0002-1670-6513"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naveen Pemmaraju","raw_affiliation_strings":["4MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":2.4154,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.90561511,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"3974","last_page":"3975"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/transfusion-dependence","display_name":"transfusion dependence","score":0.953000009059906},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/disease-burden","display_name":"disease burden","score":0.9409999847412109},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.9800000190734863},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.8489999771118164},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8309999704360962},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.6230000257492065},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.7279999852180481},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.3720000088214874},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.9629999995231628},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.6453626155853271},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5982819199562073},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5480863451957703},{"id":"https://openalex.org/C2780014101","wikidata":"https://www.wikidata.org/wiki/Q183605","display_name":"Blood transfusion","level":2,"score":0.43285804986953735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2678869366645813},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.10502538084983826}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-162657","doi":"https://doi.org/10.1182/blood-2022-162657","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-162657","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386282053","https://openalex.org/W4403099358","https://openalex.org/W7163356983","https://openalex.org/W4389229415","https://openalex.org/W4408169471","https://openalex.org/W4385706306","https://openalex.org/W4405038612","https://openalex.org/W4389243515","https://openalex.org/W4386269893","https://openalex.org/W2953370592"],"abstract_inverted_index":{"Introduction:":[0],"Myelofibrosis":[1],"(MF)":[2],"is":[3,20,67],"a":[4,21,70,427,520,537],"rare":[5],"myeloid":[6],"neoplasia":[7],"characterized":[8],"by":[9,184,244],"inflammation,":[10],"fibrosis,":[11],"and":[12,30,59,81,99,157,213,222,238,251,267,299,311,357,391,408,491,496,507,517,540],"degradation":[13],"of":[14,24,41,51,57,76,78,92,116,169,173,283,379,435,451],"the":[15,39,74,90,128,163,170,174,178,277,296,329,417,462,555],"bone":[16],"marrow":[17],"niche.":[18],"Anemia":[19,181],"key":[22],"hallmark":[23],"MF":[25,44,124,273,279,490,528,546],"which":[26,66,262],"increases":[27,338,369,499],"in":[28,127,162,197,340,370,416,453,467,479,500],"frequency":[29],"severity":[31],"with":[32,69,110,113,140,272,489,515,527,572],"disease":[33],"progression.":[34],"Janus":[35],"Kinase":[36],"inhibitors":[37],"are":[38,53],"standard":[40],"care":[42],"for":[43,123,145,249,342,440,543,557,570],"but":[45,323],"can":[46],"exacerbate":[47],"anemia.":[48],"About":[49],"one-quarter":[50],"patients":[52,109,203,215,271,284,305,334,364,424,443,456,470,482,526,547,571],"transfusion-dependent":[54],"at":[55],"time":[56],"diagnosis":[58,121,185],"nearly":[60,426],"all":[61],"will":[62],"develop":[63],"transfusion":[64,82,209,259,269,289,297,300,316,326,332,418,441,454,468,480,492,531,544,565],"dependence,":[65],"associated":[68,401,514],"poor":[71],"prognosis1":[72],"However,":[73],"burden":[75,91,542],"illness":[77,93],"MF-associated":[79],"anemia":[80],"dependence":[83,493,566],"remains":[84],"poorly":[85],"defined.":[86],"This":[87,105,552],"study":[88,107,175,553],"examined":[89,108,144],"among":[94],"these":[95,534],"patients,":[96,318],"including":[97,154,347,372],"costs":[98,474,569],"healthcare":[100],"resource":[101],"utilization":[102],"(HCRU).":[103],"Methods:":[104],"retrospective":[106],"\u22652":[111,195],"claims":[112,131],"International":[114],"Classification":[115],"Diseases,":[117],"10th":[118],"revision":[119],"(ICD-10)":[120],"codes":[122,186],"(D75.81,":[125],"D47.4)":[126],"IBM":[129],"MarketScan":[130],"dataset":[132],"(2016-2021).":[133],"The":[134,287,447],"most":[135],"recent":[136],"two":[137],"calendar":[138,164],"years":[139],"continuous":[141,250],"enrollment":[142],"were":[143,160,207,216,274,285,324,413,475,530],"each":[146],"patient.":[147],"A":[148],"one-year":[149,521],"lookback":[150],"provided":[151],"baseline":[152],"data,":[153],"prior":[155],"treatment":[156],"comorbidities.":[158],"Outcomes":[159,228],"assessed":[161,243],"year":[165,172],"beginning":[166],"January":[167],"1":[168],"second":[171],"period":[176,522],"(i.e.,":[177],"index":[179],"date).":[180],"was":[182,192,242,292,457],"defined":[183,193],"or":[187,246,567],"anemia-related":[188],"treatments.":[189],"Transfusion":[190,201,211,362,422],"dependency":[191],"as":[194],"transfusions":[196,322],"any":[198],"one":[199],"month.":[200],"requiring":[202],"below":[204],"this":[205],"threshold":[206],"considered":[208],"independent.":[210,532],"dependent":[212,270,301,333,363,419,423,455,481,545],"independent":[214,260,298,317,442,469],"exact-matched":[217],"based":[218,233],"on":[219,234],"age,":[220],"sex,":[221],"Charlson":[223],"Comorbidity":[224],"Index":[225],"(CCI)":[226],"score.":[227],"included":[229,303],"adverse":[230],"events":[231],"(AEs;":[232],"ICD-10":[235],"codes),":[236],"HCRU,":[237,371],"costs.":[239],"Statistical":[240],"significance":[241],"t-tests":[245],"chi-squared":[247],"tests":[248],"proportional":[252],"metrics.":[253],"Results:":[254],"Prior":[255],"to":[256,403,524,561,564],"matching,":[257,295],"1535":[258],"(of":[261],"295":[263],"required":[264,320],"occasional":[265,321],"transfusions)":[266],"139":[268],"identified.":[275],"Within":[276],"total":[278,432],"population,":[280],"64%":[281],"(1072/1674)":[282],"anemic.":[286],"mean":[288,308,312,373,384,392,430,448,464],"episode":[290],"cost":[291,434,450,466,518],"US$3,790.":[293],"After":[294],"cohorts":[302],"133":[304],"(47%":[306],"female,":[307],"age":[309],"66,":[310],"CCI":[313],"3.0).":[314],"Among":[315],"30%":[319],"not":[325,513],"dependent.":[327],"In":[328],"observation":[330],"year,":[331],"showed":[335,366],"statistically":[336,367,497],"significant":[337,368,498],"(p<0.05)":[339],"risk":[341],"16":[343],"AEs":[344,502,506],"(Figure":[345,444],"1),":[346],"neutropenia":[348],"(OR":[349,352,355,360],"12.3),":[350],"thrombocytopenia":[351],"10.7),":[353],"fever":[354],"7.8),":[356],"peripheral":[358],"edema":[359],"6.1).":[361],"also":[365,458,476],"hospitalizations":[374],"(2.0":[375],"vs.":[376,382,389,396,406,411,484],"0.3),":[377],"rate":[378],"hospitalization":[380],"(75%":[381],"22%),":[383],"emergency":[385],"department":[386],"visits":[387,394,402],"(2.2":[388],"0.7),":[390],"outpatient":[393],"(48.9":[395],"9.0)":[397],"(all":[398],"p<0.05).":[399],"Non-transfusion":[400],"oncologists":[404],"(6.0":[405],"0.4)":[407],"hematologists":[409],"(2.3":[410],"0.8)":[412],"significantly":[414,459],"increased":[415],"population":[420],"(p<0.05).":[421],"had":[425],"ten-fold":[428],"higher":[429],"annual":[431],"medical":[433],"$255,190":[436],"versus":[437],"only":[438],"$27,789":[439],"2,":[445],"p<0.0001).":[446],"pharmacy":[449,465],"$60,854":[452],"greater":[460],"than":[461],"$40,038":[463],"(p=0.0118).":[471],"Patient":[472],"out-of-pocket":[473],"70%":[477],"more":[478],"($2,463":[483],"$1,450,":[485],"p=0.0003).":[486],"Conclusions:":[487],"Patients":[488],"demonstrated":[494],"substantial":[495],"many":[501],"(including":[503,511],"hematological":[504],"non-anemic":[505],"non-hematological":[508],"AEs),":[509],"HCRU":[510,512],"transfusions),":[516],"over":[519],"compared":[523],"matched":[525],"who":[529],"Overall,":[533],"results":[535],"suggest":[536],"high":[538],"clinical":[539],"economic":[541],"that":[548],"requires":[549],"further":[550],"study.":[551],"highlights":[554],"need":[556],"additional":[558],"therapeutic":[559],"options":[560],"limit":[562],"progression":[563],"offset":[568],"MF.":[573],"Figure":[574],"1View":[575,578],"largeDownload":[576,579],"PPTFigure":[577],"PPT":[580],"Close":[581],"modal":[582]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-30T00:00:00"}